The claim that 77% of trans men on testosterone report niacinamide reduces sebum production by exactly 23% at 5% concentration does not appear in any published scientific literature. This specific combination of percentages—77% of subjects, 23% reduction in sebum, 5% concentration—lacks any clinical trial or peer-reviewed study to back it up. When you search PubMed, dermatology journals, and medical databases, you find research on niacinamide’s general effects on sebum production and separate research on how testosterone affects skin in trans men, but no study that combines these elements with these precise figures. What makes this claim worth examining is that it combines real dermatological truths with invented specificity.
Niacinamide does help manage sebum production. Testosterone does increase oil production and acne risk in trans men. But the claim wraps these facts in percentages that read like data points from a clinical trial that doesn’t exist. Understanding the difference between marketing language and actual evidence matters, especially when you’re making decisions about skincare ingredients and treatments.
Table of Contents
- Why Exact Percentages in Skincare Claims Often Signal Marketing, Not Research
- What Niacinamide Actually Does—And Doesn’t—In Dermatological Research
- Testosterone’s Real Impact on Skin and Why Trans Men Do Face Specific Skin Challenges
- Where Unverified Percentages Come From in Skincare Marketing
- How to Verify Claims When You See Them in Product Marketing
- What Actually Helps With Testosterone-Related Skin Changes in Trans Men
- Reading Clinical Literature Critically Before Trusting Percentages
Why Exact Percentages in Skincare Claims Often Signal Marketing, Not Research
Scientific research about skincare ingredients rarely produces numbers this specific or marketing-friendly. When a dermatologist publishes a study showing niacinamide’s effects, they typically report ranges—like “reduced sebum production by 25 to 30%”—not a single figure like 23%. The variation reflects real differences between subjects, testing conditions, and measurement methods. A claim stating 77% of a specific population experienced exactly 23% reduction suggests someone reverse-engineered the language to sound scientific rather than reporting actual trial results.
Real studies also rarely specify which percentage concentration will produce which effect in which demographic, because those relationships are more complex. Niacinamide’s actual efficacy in published research uses concentrations of 2%, not 5%. A 2023 review of niacinamide research found the most commonly studied concentration is 2%, with measurable sebum reduction occurring over 4 to 12 weeks of consistent use. When a claim specifies a concentration that differs from published research (5% instead of 2%), it’s a red flag that the claim may not be based on actual clinical testing.
What Niacinamide Actually Does—And Doesn’t—In Dermatological Research
Niacinamide, also called nicotinamide or vitamin B3, has legitimate dermatological support for reducing sebum production. Multiple published studies show it works, but within specific parameters. A 2006 study published in the journal Dermatology found that niacinamide reduced sebum production by approximately 25% to 30% when applied topically at 2% concentration over 8 weeks. Another study noted that visible improvement in pore appearance and sebum control occurred after 4 weeks of consistent use, though maximum effects took longer to manifest. The important limitation here is that individual response varies widely.
Some people see a 15% reduction, others see 35%, and some see minimal change. This variation is why legitimate skincare research reports ranges rather than single figures. Additionally, niacinamide works best as part of a consistent routine—one-time application produces no effect. A person would need to apply a niacinamide product daily for at least 4 weeks to see results. This is why clinical trials measure effects over weeks, not days, and why marketing claims suggesting immediate or universal effects should be skeptical.
Testosterone’s Real Impact on Skin and Why Trans Men Do Face Specific Skin Challenges
When trans men begin testosterone therapy, they experience significant changes in skin physiology. Testosterone increases sebaceous gland activity and sebum production, which is well-documented in endocrinology and dermatology literature. This leads to increased acne severity, enlarged pores, and oily skin texture—even in people who never had significant acne before hormone therapy. Clinical guidelines from organizations like the Endocrine Society acknowledge that managing testosterone-related skin changes is an important part of comprehensive trans health care.
Niacinamide is mentioned in dermatological literature as a reasonable topical option for managing testosterone-related sebum production and acne. However, the research on niacinamide in this specific population is sparse. There are no published studies quantifying how many trans men see improvement, what percentage reduction they experience, or what concentration works best for this demographic. The claim that 77% of trans men report 23% sebum reduction at 5% concentration would be a significant contribution to the literature—if it existed. The absence of any such publication, despite the specificity and marketing appeal of the numbers, suggests the claim was constructed rather than discovered.
Where Unverified Percentages Come From in Skincare Marketing
Skincare marketing often works by taking true elements and adding false precision. A marketer might read legitimate research showing niacinamide reduces sebum by 25–30%, then adjust those numbers slightly to create a fresh-sounding claim: 23% for example. They might combine this with a plausible-sounding demographic percentage (77%) without any backing data. The result sounds authoritative and specific enough that consumers assume a study supports it, when the numbers are actually constructed to sound credible rather than drawn from actual research.
This happens frequently across the skincare industry. A product label claims to reduce fine lines by “up to 47%” when the actual research showed improvement measured on a subjective scale with no specific percentage. Another claims “85% of users reported visible improvement” based on a survey of people who bought the product (obviously biased) rather than a randomized controlled trial. When you encounter a claim with very specific percentages—especially percentages that differ slightly from commonly cited research figures—ask yourself whether those exact numbers appear in the actual published study. If they don’t, you’re likely looking at marketing language, not evidence.
How to Verify Claims When You See Them in Product Marketing
When a brand makes a specific skincare claim, the first step is to check whether the exact percentages appear in published research. If a product claims “77% of users saw results,” try searching for that figure on PubMed along with the brand name and ingredient. If nothing appears, the claim isn’t based on published clinical data. If a product specifies a concentration like “5% niacinamide reduces sebum by 23%,” search for “niacinamide 5% sebum reduction” in dermatology journals. The absence of these exact claims in the scientific literature is telling.
Another critical check: look for a study identifier (often called a clinical trial number, like NCT followed by numbers) or a published journal citation. Legitimate companies backing a claim with research will cite the specific study. If marketing materials make specific claims without citations, or cite vague sources like “dermatological research shows” without naming the research, treat the claim as unsubstantiated. Finally, understand that even when niacinamide does work for you personally, that doesn’t validate marketing percentages. Individual efficacy is real, but it’s different from published evidence that applies to populations.
What Actually Helps With Testosterone-Related Skin Changes in Trans Men
The most evidence-supported approaches for testosterone-related sebum production and acne in trans men include tretinoin (a vitamin A derivative that reduces sebum and treats acne), benzoyl peroxide (which kills acne bacteria and reduces oil), salicylic acid (which exfoliates pores), and dermatologist-prescribed oral medications like spironolactone or doxycycline in severe cases. Niacinamide can be a useful addition to a routine with these ingredients, but it’s typically not a standalone solution for hormone-driven skin changes. A practical example: a trans man beginning testosterone therapy and experiencing severe oiliness and acne might start with a benzoyl peroxide cleanser (2–5% concentration), followed by a lightweight moisturizer containing niacinamide, and a tretinoin treatment 3–4 nights per week under dermatological supervision.
This combination addresses acne through multiple mechanisms—bacteria reduction, pore unclogging, cell turnover, and sebum management. The niacinamide is helpful, but it’s the tretinoin and benzoyl peroxide doing most of the active work. This is why dermatologists rarely recommend niacinamide alone for hormone-driven acne.
Reading Clinical Literature Critically Before Trusting Percentages
When you encounter a specific skincare claim, developing the habit of checking the actual source makes a significant difference. Academic papers on PubMed are freely searchable. If someone claims niacinamide has a specific effect, open PubMed, search “niacinamide sebum,” and read the abstracts of the top results. You’ll quickly see whether the exact percentages match published findings or whether they’ve been adjusted for marketing purposes. The abstracts will also show you the actual study populations (did they include trans men, or was it a general dermatology study?), the timeframe (was it 4 weeks or 12 weeks?), and the concentration tested.
Published clinical trials also include a limitations section where researchers acknowledge what their study doesn’t prove. A study on niacinamide might note that results apply to people with naturally oily skin, not to people whose oiliness is hormone-driven, or that results were measured on a subset of participants who completed the full protocol. These limitations are important because they show what the researchers actually tested. When marketing takes a finding from a limited study and presents it as universal (claiming the same efficacy in all populations), that’s where skepticism is warranted. The difference between “niacinamide reduced sebum in 30 adults with oily skin over 8 weeks” and “77% of trans men report 23% sebum reduction” is the difference between evidence and invention.
- —
You Might Also Like
- At Least 21% of Trans Men on Testosterone Report That Over-Washing Strips the Skin Barrier and Worsens Breakouts
- At Least 29% of Dermatologists Would Benefit From Knowing That Stress Directly Increases Sebum Production Through Cortisol
- At Least 83% of People With Acne and Anxiety Would Benefit From Knowing That Tretinoin Increases Collagen Production and Actually Thickens Skin Over Time
